The Movement Disorder Clinic of Oklahoma is dedicated to providing patients with opportunities to participate in clinical drug studies for movement disorders. We currently offer clinical studies in treatment of Parkinson's disease, Huntington's disease, and dystonia.
Clinical Research Trials
A new study to treat off times of Parkinson's disease. This new therapy is an extended release formulation of carbidopa/levodopa tablet therapy. You must have at least 2.5 hours of off time per day on average and already use at least 4 doses of immediate release carbidopa/levodopa therapy.
A rescue therapy for Parkinson's disease patients to help with sudden or predictable off times. All patients remain on their current PD therapy and all patients will have the opportunity to use the trial medication. There is no placebo.
A novel therapy to treat Parkinson's disease psychosis.
A novel oral medication to treat moderate to severe constipation of Parkinson's disease.
We will be starting a new trial in the spring of 2019 designed to slow down the progression of Parkinson's disease. Patients may remain on all current PD medications during the trial.
A novel oral therapy to treat involuntary movements called dyskinesias.
We continue to test a new vaccine for Parkinson's disease which is currently closed to recruitment of new patients.
The Movement Disorder Clinic of Oklahoma is now a member of the Huntington's disease Study Group. Please inquire about our current clinical drug trial opportunities.
For the most up-to-date information on our clincal drug trials
contact our clinic directly at 918-392-4530 option 5